Characterisation of circulating chromogranin A in human cancer patients. - Wikidata - wikimedia - TriplyDB

Characterisation of circulating chromogranin A in human cancer patients.

Characterisation of circulating chromogranin A in human cancer patients.

http://www.wikidata.org/entity/Q40024901

about

A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout.Chromogranin A and derived peptides in health and disease A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)Chromogranin A: Novel biomarker between periodontal disease and psychosocial stress.Regulation of tumor growth by circulating full-length chromogranin A.Chromogranin A and the tumor microenvironment.The surging role of Chromogranin A in cardiovascular homeostasis.Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity.Characterization of serum and urinary chromogranin A by size exclusion chromatography: impact on calibrator selection and urinary assay.STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients.Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain.Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.Catestatin as a Target for Treatment of Inflammatory Diseases

P2860

Q28359544-9E1A9F82-8F9D-47C1-8E1D-D6DFFEB1B54D Q33738497-6606DB38-8527-4936-9B0B-BFECDBF50C52 Q36110075-33E8D962-EE34-46DF-879A-3C6AFA4B335E Q36617255-FD59CC8C-96DA-40EC-85DC-28C0FD565BA2 Q37020274-E4007F19-86C3-4DC8-B055-E38F0331D2D8 Q37687281-88D79AB0-D48B-437F-AC9E-454450C2E321 Q37809767-8C407E32-C936-419A-9733-D0F205020891 Q38245248-CA38734F-28BE-46BA-B6DC-7905B7634B10 Q39147191-A1501DE8-4130-4EEB-A74C-8909A5E26ECF Q40795001-05D76E53-3663-47B2-A127-7C52D9E8CF71 Q40905638-9CC2E10C-8D59-4761-A5F1-39BEB1EB26F7 Q42523235-BBC86282-1EAB-464A-813A-46C2040CA4BB Q42797673-6DCC3783-A24D-43F0-B862-5A898D2A8E50 Q55504118-CF967C14-8C32-4E2E-B345-5031138FD398 Q58583898-B123A6E9-8519-4328-A352-8E80CF53D003

P2860

Characterisation of circulating chromogranin A in human cancer patients.

http://www.wikidata.org/entity/Q40024901

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Characterisation of circulating chromogranin A in human cancer patients.

@en

type

label

Characterisation of circulating chromogranin A in human cancer patients.

@en

prefLabel

Characterisation of circulating chromogranin A in human cancer patients.

@en

P1433

Q40024901-2A4446CC-A274-41B4-A0E2-F28FD16D5B42

P1476

Q40024901-68D05E14-824D-426D-9EF5-DA6229542B32

P2093

Q40024901-2128ACE5-70A5-43A3-B607-F78B6AFE228D

Q40024901-64DDCCEE-D382-4972-AFE2-BC57C1C98377

Q40024901-68422CCE-4529-4B3D-A1BD-373886F14B55

Q40024901-70F50584-AF6A-4C9B-8D24-11D5A07FB773

Q40024901-AE69241F-A6ED-466B-91B9-CBFBD057B424

Q40024901-E5658F28-1019-4FE4-B595-685F0F13BA66

Q40024901-E6DE73FA-E090-4961-AAE9-0F1350C7409E

P2860

Q40024901-10805EAC-08AB-4CC6-933B-B0D86251897B

Q40024901-11409872-C906-439D-AE09-D4C055791D33

Q40024901-184EFE84-92F4-4F8C-BB39-411FC6E85614

Q40024901-21AAD24F-7625-4DDE-B0A7-BF42CB603430

Q40024901-2E02C252-1948-4AB7-BA6B-94EC25C0311F

Q40024901-3F4E8545-FA9B-4935-8451-43E152577F84

Q40024901-61CDCB56-A501-4BA8-91BE-02DEF1CBFE91

Q40024901-6F5B13CF-979B-4844-BBC1-F80F3C1A567E

Q40024901-7830019C-A8BE-45E3-910A-D24B688B494D

Q40024901-8E782F01-4EBA-4D8C-B9BE-4871B60B1E02

P2888

Q40024901-C719CC54-B982-42DE-B4F1-233FDBF8FF6F

P304

Q40024901-0575C6F4-5B66-4E4B-AD60-2091F2623014

P31

Q40024901-2CE61FAC-76A5-44F6-98A6-40F8C1E5B12E

P356

Q40024901-0FD0ACC3-9EDF-4E60-B10D-55CCDC845C6C

P407

Q40024901-62BE41A3-1D32-45FF-8045-8F539FF73181

P433

Q40024901-8441DE4D-23D2-44A9-919E-93BDA8D69E89

P478

Q40024901-65A95ED8-0DAA-4B6C-B907-327FA1AE1192

P577

Q40024901-9FB4B407-413A-4154-B03E-65A7EBA8CFBF

P5875

Q40024901-3CEF7F3F-49C9-4C18-B0FE-D8B5135D402A

P698

Q40024901-D23E7AF9-3F91-4DCD-B6E3-FA797D2A1B14

P932

Q40024901-7AEBE8FC-574E-445E-A86B-916B77E7C7AE

P356

P1433

British Journal of Cancer

P1476

Characterisation of circulating chromogranin A in human cancer patients.

@en

P2093

Brandazza A

http://www.w3.org/2001/XMLSchema#string

Chen FX

http://www.w3.org/2001/XMLSchema#string

Corti A

http://www.w3.org/2001/XMLSchema#string

Gasparri A

http://www.w3.org/2001/XMLSchema#string

Pelagi M

http://www.w3.org/2001/XMLSchema#string

Siccardi AG

http://www.w3.org/2001/XMLSchema#string

Sidoli A

http://www.w3.org/2001/XMLSchema#string

P2860

The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region

Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA

The primary structure of human chromogranin A and pancreastatin

Immunohistochemical demonstration of chromogranins A and B in neuroendocrine tumors of the lung.

Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.

Preparation of monoclonal antibodies: strategies and procedures.

The chromogranins A and B: the first 25 years and future perspectives.

Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.

Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker.

Chromogranin A. Storage and release in hypertension.

P2888

P304

924-932

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1996.183

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1996-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14589982

http://www.w3.org/2001/XMLSchema#string

P698

8611427

http://www.w3.org/2001/XMLSchema#string

P932

2075816

http://www.w3.org/2001/XMLSchema#string